Alexander Levy
@AlexLevyMD
Followers
390
Following
1K
Media
4
Statuses
80
Assistant Profressor @YaleDigestive, Director of Yale IBD Fellowship Program, Passionate about #IBD patient care
New Haven, CT
Joined April 2023
Amazing work by our fellow @Montalvan214 and the @CrohnsColitisFn putting together this resource for our Spanish speaking #IBD patients @YaleDigestive
🌟 Check out the latest video for Spanish-speaking patients about IBD! 🌟 Thanks to @CrohnsColitisFn and @AlexLevyMD for all the support. 🙏📹💙 #IBDawareness
https://t.co/xwli40obfP
1
2
10
1
1
8
We are so excited to introduce our gastroenterology/hepatology fellows for 2025! welcome to the yale family!
5
13
87
I am delighted to announce that the @YaleDigestive IBD program is accepting applications for our Advanced IBD Fellowship position for the 2026-27 academic year! Visit https://t.co/HYLGOOIBri for more information.
medicine.yale.edu
Completing an inflammatory bowel disease fellowship provides a well-rounded clinical and research experience in IBD, and prepares the fellow for a career managing the most complex IBD patients.
0
4
26
We are thrilled to announce the 2024 Sherman Prize Recipients, @MLongMD, @UNC @UNC_SOM @UNCGastro & @doc_ibd, @IBDCedarsSinai @CedarsSinai, & the Emerging Leader Prize Recipient, @DrJordanAxelrad, @nyulangone @nyugrossman. Learn more about the honorees at https://t.co/X1oIieTLBm
18
29
120
How long after admission for acute severe UC should patients follow up with GI? 🧐 ⭐️ Follow up within 🥇 week = ⬇️ risk of readmissions 🔑 Follow up can be with IBDologist, general GI or APP https://t.co/0fzV37oSP7
@Stanford_GI @PhilipOkaforMD
0
6
22
THE RISK OF IBD IN OFFSPRING INCREASES IF EITHER PARENT HAS IBD BEFORE CHILDBIRTH 👩🏻👨🏾👶🏼 New Study in Gut shows that both maternal and paternal IBD diagnosis before childbirth is associated with higher IBD risk in offspring. Read the study here ➡️ https://t.co/9ug0wXGuNl
2
21
53
Had a wonderful time with my family at the Connecticut/Westchester Take Steps event yesterday. I am thankful for the opportunity to connect with our IBD community and support such a great cause. Go Yale Stoma Troopers! @CrohnsColitisFn #IBD #takesteps
0
1
16
Thank you to the Crohn’s & Colitis Foundation CT/Westchester chapter for the support. Thinking of donating to our team? Click on the link. #takesteps
https://t.co/gWQzD7jDOs
instagram.com
0
0
4
Registration open for the Yale #IBD conference on 4/19/24 @WatersEdgeCT featuring... @Badr_AlBawardy @AlexLevyMD @JillGaidosMD @DebProctorMD @IraLeeds_MD @haddonjpantel & special guest @EdwardLoftus2 of @MayoClinicGIHep
@YaleCME 🔗👇 https://t.co/vV5z1Lu3Yp
0
7
13
Excited to share our study on IUS as screening tool for Crohn's disease clinical trials and validation of IUS activity scores @AmJGastro - Problem: Failure to meet SES-CD is #1 reason for trial screen failures = un. scopes - Answer: IUS prior to scope can reduce this by 90%
0
25
88
Always great to catch up with old friends and learn more about IBD @DorianJonesMD @IBDConference #AIBD2023
0
0
4
The impact of IBD on a person's life is not just physical Physical aspects • diarrhoea, urgency, blood in stool and pain • loss of appetite and weight loss • night sweats and fevers • nausea and vomiting • joint pains, eye problems, skin rashes and mouth ulcers
4
32
126
Good luck to all fellowship applicants for #MatchDay2023! 🤞
0
2
16
🎯Is #TransmuralHealing the next T2T in #Crohns? 🧰#IUS + FCP for proactive monitoring & adjusting Rx? 🔎TH= Bowel wall <3mm + No Doppler vascular activity ⏳Benefit mainly early (<18mos) Crohns? 💰Monitoring< prevented complications 🚧Achieved only in 30-50% of pts in studies
🆕@uegjournal 🎯 Transmural remission as a treatment target in #crohns disease 🗝️Requires close monitoring 💊Pivot quickly to new therapies 📣Better disease control @alearmuzzi @silvio_silvio75 @LumirKunovsky @MariangelaAllo3 @saramassironi 🔗 https://t.co/LJnT92QZxW
2
16
31
Higher visceral adipose fat associated with higher infliximab level needed for remission in #ibd Nice study @AndresYarur ! https://t.co/u41EQSbUhY
journals.lww.com
et trough levels of infliximab associated with favorable outcomes. The aim of this study was to assess whether VAT burden may be associated with infliximab cutoffs associated with efficacy in...
0
8
21
🚨 New publication alert🚨 Our recent systematic review showed HBOT to be effective and safe option for fistulizing Crohn's. ⭐️ 87% clinical response ⭐️ Low adverse events - only 51 per 10,000 HBOT sessions https://t.co/aMZgJxhW4A
0
4
15
Biologics in pregnancy overall are low risk and data across studies and drugs are consistent. We continue throughout pregnancy and lactation.
Safety of VDZ &UST in pregnancy from #PIANO. Reassuring data from @RishikaChughMD @MLongMD @drdawnbeaulieu @UmaMahadevanIBD
1
33
100
@MondayNightIBD @Waseem_AhmedMD @ZachBormanMD @ericohenr @DamieOdufaluMD @ManasiAgrawalMD @PriSantiagoMD @VictorChedidMD @AdamFayeMD @dunleavy_katie @KatieFalloonMD 1/ Thinking about an #IBDFellowship? Need tips on how to navigate the #IBD #fellowship application?🤔 🎯This tweetorial will cover the basics🧩 📲Send us your Questions by September 16, to be answered by IBD PDs & faculty during our webinar on 10/9/23: https://t.co/d6JXDAsVmI
2
13
32